- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We're Reading: CMS Wants to Penalize Doctors for Prostate Tests
What we're reading, November 20, 2015: CMS wants to penalize doctors for ordering routine prostate-cancer screening tests; lawmakers, patients, and advocates call for head of Drug Enforcement Agency to be fired; and specialty drug costs exceed household incomes.
CMS Looking to Penalize Doctors Ordering Routine Prostate Tests
Doctors who order routine prostate-cancer screening tests for their patients could be penalized by Medicare as part of an effort to define quality in healthcare. According to the Wall Street Journal, in just the past 2 days, the proposal has garnered more than 200 comments, virtually all in opposition because the measure would discourage doctors from discussing the pros and cons of screening for prostate-specific antigen with their patients. The comment period ends Friday.
Lawmakers Call for Removal of DEA Head
Lawmakers from both parties are calling on President Obama to fire the acting leader of the Drug Enforcement Administration, Chuck Rosenberg. The lawmakers and nearly 100,000 people who have signed an online petition are calling for Rosenberg’s removal after calling medical marijuana “a joke,” reported the Washington Post. Earlier he had commented that marijuana was “probably not” as dangerous as heroin.
Specialty Drug Costs Exceed Median Household Income
Prices for specialty drugs reached an average annual cost of more than $53,000 in 2013, which exceeds the median US household income of $52,250, according to an AARP Public Policy Institute report. The annual cost, which is calculated for specialty medications used on a chronic basis, is more than twice the median income for people on Medicare and almost 3-and-a-half times higher than the average Social Security retirement benefit, reported Drug Store News.
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
